✦ LIBER ✦

CD22 monoclonal antibody therapies in relapsed/refractory acute lymphoblastic leukemia

✍ Scribed by Hoelzer, Dieter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of inotuzumab ozogamicin, a CD22

✍ Kantarjian, Hagop; Thomas, Deborah; Jorgensen, Jeffrey; Kebriaei, Partow; Jabbou 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

Monoclonal Antibody Therapy with Rituxim

✍ Thomas, Deborah A.; O'Brien, Susan; Kantarjian, Hagop M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 809 KB

Treatment of relapsed or refractory acut

✍ Feldman, E; Kalaycio, M; Weiner, G; Frankel, S; Schulman, P; Schwartzberg, L; Ju 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Outcome of risk adapted therapy for rela

✍ Belgaumi, Asim F.; Al-Seraihy, Amal; Siddiqui, Khawar S.; Ayas, Mouhab; Bukhari, 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 367 KB

FLAG-IDA in the treatment of refractory/

✍ G. Specchia; D. Pastore; P. Carluccio; A. Liso; A. Mestice; R. Rizzi; L. Ciuffre 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 81 KB

Anti-CD22 therapy in acute lymphoblastic

✍ Dieter Hoelzer 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 134 KB